U.S. Court of Appeals for the Federal Circuit
Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc.
This writing
- Type
- Opinion
- Filed
- Sept. 23, 2025
- Case
- Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc.
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Case: 23-2434 Document: 78 Page: 1 Filed: 09/23/2025 United States Court of Appeals for the Federal Circuit ______________________ BAYER PHARMA AKTIENGESELLSCHAFT, Appellant v. MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS USA, INC., INVAGEN PHARMACEUTICALS INC., Appellees ______________________ 2023-2434 __…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.